Results 371 to 380 of about 677,866 (413)
Some of the next articles are maybe not open access.
Treatment of acute ischemic stroke
Journal of Stroke and Cerebrovascular Diseases, 2001Acute ischemic stroke remains difficult to treat despite the advent of new therapies. The only approved medication to reverse its effects is recombinant tissue plasminogen activator administered intravenously within 3 hours of onset of stroke symptoms--an opportunity that does not often present itself. The principal drawback to thrombolytic therapy for
openaire +2 more sources
Management of Acute Ischemic Stroke
Mayo Clinic Proceedings, 2004The treatment of acute ischemic stroke has evolved from observation and the passage of time dictating outcome to an approach that emphasizes time from ictus, rapid response, and a dedicated treatment team. We review the treatment of acute ischemic stroke from the prehospital setting, to the emergency department, to the inpatient hospital setting.
Jimmy R, Fulgham +5 more
openaire +2 more sources
Thrombolysis for Acute Ischemic Stroke
Neurosurgery Clinics of North America, 1997The use of thrombolytic agents to restore cerebral blood flow is one of the most notable advances in the treatment of ischemic stroke. This article reviews thrombolytic therapy, its limitations, and the techniques by which thrombolytic agents can be delivered.
D M, Landis, R W, Tarr, W R, Selman
openaire +2 more sources
Acute Ischemic Stroke Management
Thrombosis Research, 2000The use of thrombolytic therapy represents one of many recent developments in the management of acute ischemic stroke. The development of stroke teams and protocols has been driven by these new demands for an urgent response to ischemic stroke. The short time window of 3 hours for therapy with intravenous recombinant tissue plasminogen activator ...
R P, Atkinson, C, DeLemos
openaire +2 more sources
Alteplase for acute ischemic stroke
Expert Review of Cardiovascular Therapy, 2006Alteplase, an intravenously administered form of recombinant tissue plasminogen activator (rt-PA), remains the only US FDA-approved thrombolytic treatment for acute ischemic stroke within 3 h of symptom onset. Patients treated with intravenous rt-PA are at least 30% more likely to have minimal or no disability at 3 months compared with placebo. Despite
Nicole R, Gonzales, James C, Grotta
openaire +2 more sources
Immunothrombosis in Acute Ischemic Stroke
StrokeIschemic stroke is one of the leading causes of disability and mortality worldwide. Thrombosis is the main pathological process of stroke and is therefore an important therapeutic target in stroke prevention. In recent years, with the development of endovascular treatment and therefore retrieving the thrombus for further investigation, evidence is ...
Yan Wang +4 more
openaire +2 more sources
Imaging of acute ischemic stroke
Emergency Radiology, 2018For decades, imaging has been a critical component of the diagnostic evaluation and management of patients suspected of acute ischemic stroke (AIS). With each new advance in the treatment of AIS, the role of imaging has expanded in scope, sophistication, and importance in selecting patients who stand to benefit from potential therapies.
Scott, Rudkin +3 more
openaire +2 more sources
Neurologic Clinics, 2000
Acute ischemic stroke is a medical emergency that requires rapid evaluation and treatment. Prehospital and emergency department care can be streamlined to meet those goals. Intravenous rt-PA therapy improves outcome in selected patients with ischemic stroke if given within 3 hours of stroke onset, but offers no benefit beyond that time window.
S L, Hickenbottom, W G, Barsan
openaire +2 more sources
Acute ischemic stroke is a medical emergency that requires rapid evaluation and treatment. Prehospital and emergency department care can be streamlined to meet those goals. Intravenous rt-PA therapy improves outcome in selected patients with ischemic stroke if given within 3 hours of stroke onset, but offers no benefit beyond that time window.
S L, Hickenbottom, W G, Barsan
openaire +2 more sources
Troponin T in Acute Ischemic Stroke
The American Journal of Cardiology, 2013Multiple interactions are considered to occur among the various forms of cardiovascular and cerebrovascular diseases. The aim of this study was to assess the serum level profile of cardiac troponin T (cTnT) in patients with acute ischemic stroke (AIS) to evaluate factors associated with increased serum levels of cTnT. Patients with AIS enrolled in this
Michal, Král +12 more
openaire +2 more sources
2016
Acute ischemic stroke is common and often treatable, but treatment requires reliable information on the state of the brain that may be provided by modern neuroimaging. Critical information includes: the presence of hemorrhage; the site of arterial occlusion; the size of the early infarct "core"; and the size of underperfused, potentially threatened ...
R Gilberto, González, Lee H, Schwamm
openaire +2 more sources
Acute ischemic stroke is common and often treatable, but treatment requires reliable information on the state of the brain that may be provided by modern neuroimaging. Critical information includes: the presence of hemorrhage; the site of arterial occlusion; the size of the early infarct "core"; and the size of underperfused, potentially threatened ...
R Gilberto, González, Lee H, Schwamm
openaire +2 more sources